Evogene Reports Third Quarter 2022 Financial Results
November 17, 2022
Ryan Allway November 17th, 2022 News, Top News Conference call and webcast: today, November 17, 2022, 9:00 am ET REHOVOT, Israel, Nov. 17, 2022 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science based product discovery and development utilizing cutting edge computational biology technologies, across multiple... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Halo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)
May 17, 2022
Ryan Allway May 17th, 2022 News, Top News TORONTO, May 17, 2022 /CNW/ – Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced its financial and operational results for three months ended March 31, 2022 (“Q1 2022”). Halo’s book value- booking investments at actual adjust costs basis... Read more
InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
November 10, 2021
Ryan Allway November 10th, 2021 VANCOUVER, British Columbia., Nov. 10, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced financial results for the first quarter of fiscal year 2022 which ended September 30,... Read more
